4.7 Review

Therapeutic regulation of autophagy in hepatic metabolism

期刊

ACTA PHARMACEUTICA SINICA B
卷 12, 期 1, 页码 33-49

出版社

INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2021.07.021

关键词

Autophagy; Liver metabolism; Signaling proteins; Lysosome; Nutrient regeneration; Quality control; Farnesoid X receptor; Cryptochrome 1

资金

  1. Tulane University School of Medicine Endowment Fund (USA)
  2. American Society for Investigative Pathology (ASIP/SROPP) (USA)
  3. BeHEARD Rare Disease challenge 2020 (USA)

向作者/读者索取更多资源

Autophagy plays an important role in hepatic energy regulation, not only selectively regulating the expression levels of metabolic enzymes and signaling proteins, but also influencing nutrient regeneration and organelle quality control. Autophagy modulation has broad potential in the treatment of metabolic disorders.
Metabolic homeostasis requires dynamic catabolic and anabolic processes. Autophagy, an intracellular lysosomal degradative pathway, can rewire cellular metabolism linking catabolic to anabolic processes and thus sustain homeostasis. This is especially relevant in the liver, a key metabolic organ that governs body energy metabolism. Autophagy's role in hepatic energy regulation has just begun to emerge and autophagy seems to have a much broader impact than what has been appreciated in the field. Though classically known for selective or bulk degradation of cellular components or energy-dense macromolecules, emerging evidence indicates autophagy selectively regulates various signaling proteins to directly impact the expression levels of metabolic enzymes or their upstream regulators. Hence, we review three specific mechanisms by which autophagy can regulate metabolism: A) nutrient regeneration, B) quality control of organelles, and C) signaling protein regulation. The plasticity of the autophagic function is unraveling a new therapeutic approach. Thus, we will also discuss the potential translation of promising preclinical data on autophagy modulation into therapeutic strategies that can be used in the clinic to treat common metabolic disorders. (C) 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据